BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS




 Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb Company
Employees:
Symbol: BMY
 





Collaborations

Gilead Sciences, Inc. 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys, Inc.  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead Sciences, Inc. (Durham, NC) 

Phyton Biotech, Inc.  - Cancer

Gilead Sciences, Inc. (Seattle, WA) 





 Company News
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Won’t Have To Face Kickback Lawsuit 10/21/2014 5:31:34 AM
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), And Janssen Research & Development Announce Clinical Collaboration To Evaluate OPDIVO® (Nivolumab) And IMBRUVICA®(Ibrutinib) In Non-Hodgkin Lymphoma 10/13/2014 8:44:15 AM
Bristol-Myers Squibb Company (BMY) Statement On Sustiva (Efavirenz) In The U.S. 10/8/2014 11:13:15 AM
Bristol-Myers Squibb Company (BMY) Withdraws NDA For Asunaprevir 10/7/2014 7:08:09 AM
Bristol-Myers Squibb Company (BMY) And MD Anderson Cancer Center Announce Novel Research Collaboration In Immuno-Oncology Focused On Leukemia And Hematologic Malignancies 10/6/2014 8:24:14 AM
Novartis AG (NVS) Teams Up With Bristol-Myers Squibb Company (BMY) To Test Lung Cancer Drugs 10/6/2014 5:54:18 AM
NeurOp Corporation Receives Milestone Payment As Bristol-Myers Squibb Company (BMY) Nominates NMDA Receptor Compound As Drug Development Candidate 10/3/2014 10:11:39 AM
Allied-Bristol Life Sciences Taps Ex-Bristol-Myers Squibb Company (BMY) Exec To Lead Drug Discovery From Academic Institutions 10/3/2014 6:13:30 AM
Bristol-Myers Squibb Company (BMY) To Announce Results For Third Quarter On October 24 10/1/2014 10:19:02 AM
Gilead Sciences, Inc. (GILD) Looks To Erase Bristol-Myers Squibb Company (BMY)'s Early Hep C Lead 9/30/2014 7:05:34 AM
12345678910...